The central premise underlying the San Antonio Nathan Shock Aging Center described in this proposal is that identifying the biological mechanisms underlying aging can best be achieved by studying animal models that show enhanced longevity. Our Center will focus its effort on providing investigators with State-of-the-art scientific infrastructure, resources, services, and unique animal models that are required in studying pertinent questions to the basic biology of aging in mammalian models of enhanced longevity. The Specific Objectives of the San Antonio Nathan Shock Aging Center are as follows: 1. To provide mammalian models of interest to investigators studying aging. The Aging Animal and Longevity Assessment Core will provide investigators with various rodent models of interest to aging, e.g., transgenic/nutritional/pharmacological manipulations, and the Comparative Biology of Aging Core will provide investigators with mammalian species with exceptionally long lifespans. 2. To provide services/resources that will allow investigators to study various molecular and physiological processes believed to play a role in aging in rodents. The Pathology, Oxidative Damage and Mitochondrial Function, Healthspan and Functional Assessment, and Research Development Cores will provide investigators with unique resources/services used to characterize the effect of the various manipulations on aging in whole animals, tissues, or cells. In addition, the Administrative/ Program Enrichment Core will provide investigators with support for data management and statistical analyses. 3. To provide assistance to faculty for developing research programs in aging. The Research Development Core will provide investigators new to aging with pilot grants and mentors to develop research programs in aging that can successfully compete for research grants from federal and private sources. 4. The Administrative/Program Enrichment Core will provide the administrative support necessary to enhance the research environment in San Antonio and to encourage collaborative research on aging among investigators at San Antonio as well as other Nathan Shock Centers and institutions. Over the past 5 years, the San Antonio Nathan Shock Aging Center has provided services to 103 investigators, and 30% of these investigators are from other research institutions.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Center Core Grants (P30)
Project #
5P30AG013319-20
Application #
8701167
Study Section
Special Emphasis Panel (ZAG1)
Program Officer
Sierra, Felipe
Project Start
1997-07-15
Project End
2015-06-30
Budget Start
2014-08-15
Budget End
2015-06-30
Support Year
20
Fiscal Year
2014
Total Cost
Indirect Cost
Name
University of Texas Health Science Center
Department
Pharmacology
Type
Schools of Medicine
DUNS #
City
San Antonio
State
TX
Country
United States
Zip Code
78229
Van Skike, Candice E; Jahrling, Jordan B; Olson, Angela B et al. (2018) Inhibition of mTOR protects the blood-brain barrier in models of Alzheimer's disease and vascular cognitive impairment. Am J Physiol Heart Circ Physiol 314:H693-H703
Mao, Kai; Quipildor, Gabriela Farias; Tabrizian, Tahmineh et al. (2018) Late-life targeting of the IGF-1 receptor improves healthspan and lifespan in female mice. Nat Commun 9:2394
Lee, Hak Joo; Feliers, Denis; Barnes, Jeffrey L et al. (2018) Hydrogen sulfide ameliorates aging-associated changes in the kidney. Geroscience 40:163-176
Kang, Donghoon; Kirienko, Daniel R; Webster, Phillip et al. (2018) Pyoverdine, a siderophore from Pseudomonas aeruginosa, translocates into C. elegans, removes iron, and activates a distinct host response. Virulence 9:804-817
Hook, Michael; Roy, Suheeta; Williams, Evan G et al. (2018) Genetic cartography of longevity in humans and mice: Current landscape and horizons. Biochim Biophys Acta Mol Basis Dis 1864:2718-2732
Van Skike, Candice E; Galvan, Veronica (2018) A Perfect sTORm: The Role of the Mammalian Target of Rapamycin (mTOR) in Cerebrovascular Dysfunction of Alzheimer's Disease: A Mini-Review. Gerontology 64:205-211
Kraig, Ellen; Linehan, Leslie A; Liang, Hanyu et al. (2018) A randomized control trial to establish the feasibility and safety of rapamycin treatment in an older human cohort: Immunological, physical performance, and cognitive effects. Exp Gerontol 105:53-69
Ungvari, Zoltan; Tarantini, Stefano; Donato, Anthony J et al. (2018) Mechanisms of Vascular Aging. Circ Res 123:849-867
Weiss, Roxanne; Fernandez, Elizabeth; Liu, Yuhong et al. (2018) Metformin reduces glucose intolerance caused by rapamycin treatment in genetically heterogeneous female mice. Aging (Albany NY) :
Qin, Kunhua; Zhang, Ning; Zhang, Zhao et al. (2018) SIRT6-mediated transcriptional suppression of Txnip is critical for pancreatic beta cell function and survival in mice. Diabetologia 61:906-918

Showing the most recent 10 out of 231 publications